Intelligence · Clinical Pipeline
SUPERNUS PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at SUPERNUS PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 23
Quick answer
SUPERNUS PHARMACEUTICALS has 23 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
BIS-001ER
SUPERNUS PHARMACEUTICALS, INC.
Focal Impaired Awareness Seizures
1 trial -
Botulinum Toxin Type B (Myobloc)
SUPERNUS PHARMACEUTICALS, INC.
Drooling
1 trial -
Brexanolone
SUPERNUS PHARMACEUTICALS, INC.
Tinnitus
1 trial -
Gocovri (extended-release amantidine)
SUPERNUS PHARMACEUTICALS, INC.
Radiation Encephalopathy
1 trial -
Huperzine A, Huperzine A, Capsules, Huperzine A
SUPERNUS PHARMACEUTICALS, INC.
Focal Onset Seizures
1 trial -
IR Viloxazine
SUPERNUS PHARMACEUTICALS, INC.
Attention-Deficit/Hyperactivity Disorder (ADHD)
1 trial -
IR-TPM (Topamax)
SUPERNUS PHARMACEUTICALS, INC.
Migraine
1 trial -
Molindone
SUPERNUS PHARMACEUTICALS, INC.
Impulsive Aggression Comorbid With ADHD in Children
1 trial -
NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Major Depressive Disorder
1 trial -
NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Treatment Resistant Depression
1 trial -
SAGE-547
SUPERNUS PHARMACEUTICALS, INC.
Postpartum Depression
1 trial -
SAGE-547
SUPERNUS PHARMACEUTICALS, INC.
Severe Postpartum Depression
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Mild Cognitive Impairment
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Alzheimer Disease
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Huntington Disease
2 trials -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Parkinson Disease
1 trial -
SAGE-718-matching placebo
SUPERNUS PHARMACEUTICALS, INC.
Parkinson Disease
1 trial -
SPN-810
SUPERNUS PHARMACEUTICALS, INC.
Attention Deficit Disorder With Hyperactivity
1 trial -
SPN-810
SUPERNUS PHARMACEUTICALS, INC.
Impulsive Aggression Comorbid With ADHD
1 trial -
SPN-817
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial -
SPN-817
SUPERNUS PHARMACEUTICALS, INC.
Focal Onset Seizures
2 trials -
SPN-821 2400 mg
SUPERNUS PHARMACEUTICALS, INC.
Major Depressive Disorder (MDD)
1 trial -
TPM XR
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial
Frequently asked questions
How many pipeline programs does SUPERNUS PHARMACEUTICALS have?
23 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs